Bristol Myers Squibb Long Term Deferred Charges (Quarterly) Analysis

Bristol Myers Squibb Co. (BMY)

60.66 +0.36 (+0.60%) USD | NYSE | Feb 20, 16:00

60.66 0.00 (0.00%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for BMY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Gilead Sciences, Inc.	--
Regeneron Pharmaceuticals, Inc.	--
Janux Therapeutics, Inc.	--
Moderna, Inc.	--